Health care costs

Speaker of the House Nancy Pelosi, D-Calif., arrives for a gathering of the House Democratic Caucus at the Capitol in Washington, Tuesday, Sept. 10, 2019. A leaked draft proposal from Pelosi says Medicare should overhaul how it pays for prescription drugs, by negotiating prices for the costliest medications, curbing year-to-year price hikes, and limiting what seniors pay out of their own pockets. (AP Photo/J. Scott Applewhite)
September 10, 2019 - 4:19 pm
WASHINGTON (AP) — A draft plan from House Speaker Nancy Pelosi leaked Tuesday would overhaul how Medicare pays for prescription drugs, by negotiating prices for costly medications, curbing annual price hikes, and limiting what seniors pay out of their own pockets. With President Donald Trump highly...
Read More
Democratic presidential candidate former Vice President Joe Biden speaks during a campaign event at Keene State College in Keene, N.H., Saturday, Aug. 24, 2019. (AP Photo/Michael Dwyer)
August 27, 2019 - 12:29 pm
WASHINGTON (AP) — Wrapping himself in the legacy of "Obamacare," Joe Biden is offering restless Democrats a health care proposal that goes far beyond it, calling for a government plan almost anybody can join but stopping short of a total system remake. Recent polls show softening support for the...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 2:00 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to. That's according to an Associated Press analysis of drug prices provided by health information firm Elsevier. After years of frequent list price hikes...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 2:19 pm
WASHINGTON (AP) — The Trump administration said Wednesday it will create a way for Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of refusals by health authorities amid a public outcry over high prices for life-sustaining...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 10:48 am
WASHINGTON (AP) — The Latest on President Donald Trump's plan to lower prescription drug prices (all times local): 11:40 a.m. The drug industry lobby says the Trump administration's plan to let Americans import cheaper prescription drugs from Canada is "far too dangerous." Pharmaceutical Research...
Read More
FILE - In this June 18, 2019, file photo, U.S. Trade Representative Robert Lighthizer testifies before the Senate Finance Committee on Capitol Hill in Washington. Congressional Democrats appear to be moving from “no way’’ to “maybe’’ on President Donald Trump’s rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with Lighthizer, most recently on Friday, July 26, and both sides say they are making progress toward a deal that would clear the way for Congress to approve Trump’s U.S.-Mexico-Canada Agreement, or USMCA. (AP Photo/Susan Walsh, File)
July 30, 2019 - 2:21 pm
WASHINGTON (AP) — Congressional Democrats appear to be moving from "no way" to "maybe" on President Donald Trump's rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with U.S. Trade Representative Robert Lighthizer, most recently on Friday, and both sides say they...
Read More
FILE - In this Jan. 28, 2019, file photo, Bonnie Bowman, a supporter of a voter-approved measure to fully expand Medicaid, gathers with others during a rally at the Utah state Capitol, urging lawmakers not to change the law. President Donald Trump's administration has rejected Utah's planned request for enhanced federal funding for partial expansion of its Medicaid program, state officials said Saturday, July 27. (AP Photo/Rick Bowmer, File)
July 29, 2019 - 5:17 pm
SALT LAKE CITY (AP) — The Trump administration's rejection of Utah's plan to partially expand Medicaid could send other states back to the drawing board on covering more low-income people under President Barack Obama's signature health care law. The decision is disappointing for leaders in...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 2:59 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 9:49 am
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. The two companies said Monday that they'll ultimately spin off the combination of Mylan, a $10 billion company, with Pfizer...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor. (AP Photo/Elise Amendola, File)
July 25, 2019 - 7:15 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More

Pages